Ikarian Capital »

Hookipa Pharma Inc equity shares owned by Ikarian Capital

Quarter-by-quarter ownership of Hookipa Pharma Inc equity (HOOK) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Hookipa Pharma Inc equity

Tip: Access up to 7 years of quarterly data

All positions including Hookipa Pharma Inc equity held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hookipa Pharma Inc equity by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $430k 531k 0.81
2023-09-30 $327k 531k 0.62
2023-06-30 $528k 600k 0.88

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Hookipa Pharma Inc equity

Baker Bros. Advisors
Artal Group
Knoll Capital Management
EcoR1 Capital
Vanguard Group
Redmile Group
Ikarian Capital
Royal Bank of Canada
Two Sigma Securities
Millennium Management
Tyler-Stone Wealth Management
Charles Schwab Investment Management
DLK Investment Management
Beacon Pointe Advisors
Apella Capital

View all funds holding Hookipa Pharma Inc equity